Skip to main content
Top
Published in: Breast Cancer Research 6/2005

Open Access 01-12-2005 | Research article

Allelic imbalances of chromosomes 8p and 18q and their roles in distant relapse of early stage, node-negative breast cancer

Authors: Aki Morikawa, Tanisha Y Williams, Luc Dirix, Cecile Colpaert, Michael Goodman, Robert H Lyles, Diansheng Zhong, Wei Zhou

Published in: Breast Cancer Research | Issue 6/2005

Login to get access

Abstract

Introduction

Identification of breast cancer patients at risk for postoperative distant relapse is an important clinical issue. Existing pathological markers can predict disease recurrence only to a certain extent, and there is a need for more accurate predictors.

Methods

Using 'counting alleles', a novel experimental method, we determined allelic status of chromosomes 8p and 18q in a case-control study with 65 early stage, node negative, invasive ductal carcinomas (IDCs). The association between allelic imbalance (AI) of both chromosomal markers and distant relapses was examined.

Results

Eighty percent of tumors contained 8pAI and sixty-eight percent of tumors contained 18qAI. However, none of the tumor samples retained both chromosome 8p and 18q alleles. More importantly, tumors with 8pAI but not 18qAI were more likely to have distant relapse compared to tumors with 18qAI but not 8pAI.

Conclusion

Our finding suggests that differential allelic loss of chromosomes 8p and 18q may represent subtypes of early stage IDC with different tumor progression behaviors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, McCarron P, Parkin DM: The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004, 6: 229-239. 10.1186/bcr932.CrossRefPubMedPubMedCentral Bray F, McCarron P, Parkin DM: The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004, 6: 229-239. 10.1186/bcr932.CrossRefPubMedPubMedCentral
2.
go back to reference Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ: Cancer statistics, 2004. CA Cancer J Clin. 2004, 54: 8-29.CrossRefPubMed Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ: Cancer statistics, 2004. CA Cancer J Clin. 2004, 54: 8-29.CrossRefPubMed
3.
4.
go back to reference Thiagalingam S, Foy RL, Cheng KH, Lee HJ, Thiagalingam A, Ponte JF: Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr Opin Oncol. 2002, 14: 65-72. 10.1097/00001622-200201000-00012.CrossRefPubMed Thiagalingam S, Foy RL, Cheng KH, Lee HJ, Thiagalingam A, Ponte JF: Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr Opin Oncol. 2002, 14: 65-72. 10.1097/00001622-200201000-00012.CrossRefPubMed
5.
go back to reference Zhou W: Mapping genetic alterations in tumors with single nucleotide polymorphisms. Curr Opin Oncol. 2003, 15: 50-54. 10.1097/00001622-200301000-00007.CrossRefPubMed Zhou W: Mapping genetic alterations in tumors with single nucleotide polymorphisms. Curr Opin Oncol. 2003, 15: 50-54. 10.1097/00001622-200301000-00007.CrossRefPubMed
6.
go back to reference Zhou W, Williams T, Colpaert C, Morikawa A, Zhong D: Digital PCR analysis of allelic status in clinical specimens. DNA Amplification: Current Technologies and Applications. Edited by: Demidov VV, Broude NE. 2004, Norfolk: Horizon Bioscience, 335- Zhou W, Williams T, Colpaert C, Morikawa A, Zhong D: Digital PCR analysis of allelic status in clinical specimens. DNA Amplification: Current Technologies and Applications. Edited by: Demidov VV, Broude NE. 2004, Norfolk: Horizon Bioscience, 335-
7.
go back to reference Zhou W, Galizia G, Lieto E, Goodman SN, Romans KE, Kinzler KW, Vogelstein B, Choti MA, Montgomery EA: Counting alleles reveals a connection between chromosome 18q loss and vascular invasion. Nat Biotechnol. 2001, 19: 78-81. 10.1038/86777.CrossRefPubMed Zhou W, Galizia G, Lieto E, Goodman SN, Romans KE, Kinzler KW, Vogelstein B, Choti MA, Montgomery EA: Counting alleles reveals a connection between chromosome 18q loss and vascular invasion. Nat Biotechnol. 2001, 19: 78-81. 10.1038/86777.CrossRefPubMed
9.
go back to reference Tyagi S, Kramer FR: Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol. 1996, 14: 303-308. 10.1038/nbt0396-303.CrossRefPubMed Tyagi S, Kramer FR: Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol. 1996, 14: 303-308. 10.1038/nbt0396-303.CrossRefPubMed
10.
go back to reference Tyagi S, Bratu DP, Kramer FR: Multicolor molecular beacons for allele discrimination. Nat Biotechnol. 1998, 16: 49-53. 10.1038/nbt0198-49.CrossRefPubMed Tyagi S, Bratu DP, Kramer FR: Multicolor molecular beacons for allele discrimination. Nat Biotechnol. 1998, 16: 49-53. 10.1038/nbt0198-49.CrossRefPubMed
11.
go back to reference Marras SA, Kramer FR, Tyagi S: Multiplex detection of single-nucleotide variations using molecular beacons. Genet Anal. 1999, 14: 151-156.CrossRefPubMed Marras SA, Kramer FR, Tyagi S: Multiplex detection of single-nucleotide variations using molecular beacons. Genet Anal. 1999, 14: 151-156.CrossRefPubMed
12.
go back to reference Zhou W, Goodman M, Lyles R, Lim S, Williams T, Rusthoven K, Mandel J, Amin M, Ja P: Surgical margin and gleason score as predictors of post-operative recurrence in prostate cancer with or without chromosome 8p allelic imbalance. The Prostate. 2004, 61 (1): 81-91. 10.1002/pros.20086.CrossRefPubMed Zhou W, Goodman M, Lyles R, Lim S, Williams T, Rusthoven K, Mandel J, Amin M, Ja P: Surgical margin and gleason score as predictors of post-operative recurrence in prostate cancer with or without chromosome 8p allelic imbalance. The Prostate. 2004, 61 (1): 81-91. 10.1002/pros.20086.CrossRefPubMed
13.
go back to reference Zhou W, Goodman SN, Galizia G, Lieto E, Ferraraccio F, Pignatelli C, Purdie CA, Piris J, Morris R, Harrison DJ, et al: Counting alleles to predict recurrence of early-stage colorectal cancers. Lancet. 2002, 359: 219-225. 10.1016/S0140-6736(02)07448-2.CrossRefPubMed Zhou W, Goodman SN, Galizia G, Lieto E, Ferraraccio F, Pignatelli C, Purdie CA, Piris J, Morris R, Harrison DJ, et al: Counting alleles to predict recurrence of early-stage colorectal cancers. Lancet. 2002, 359: 219-225. 10.1016/S0140-6736(02)07448-2.CrossRefPubMed
14.
go back to reference Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B: Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res. 2001, 61: 818-822.PubMed Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B: Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res. 2001, 61: 818-822.PubMed
15.
go back to reference Colpaert C, Vermeulen P, Jeuris W, van Beest P, Goovaerts G, Weyler J, Van Dam P, Dirix L, Van Marck E: Early distant relapse in 'node-negative' breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol. 2001, 193: 442-449. 10.1002/path.829.CrossRefPubMed Colpaert C, Vermeulen P, Jeuris W, van Beest P, Goovaerts G, Weyler J, Van Dam P, Dirix L, Van Marck E: Early distant relapse in 'node-negative' breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol. 2001, 193: 442-449. 10.1002/path.829.CrossRefPubMed
17.
go back to reference Buerger H, Gebhardt F, Schmidt H, Beckmann A, Hutmacher K, Simon R, Lelle R, Boecker W, Brandt B: Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression. Cancer Res. 2000, 60: 854-857.PubMed Buerger H, Gebhardt F, Schmidt H, Beckmann A, Hutmacher K, Simon R, Lelle R, Boecker W, Brandt B: Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression. Cancer Res. 2000, 60: 854-857.PubMed
18.
go back to reference Beckmann MW, Niederacher D, Schnurch HG, Gusterson BA, Bender HG: Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med. 1997, 75: 429-439. 10.1007/s001090050128.CrossRefPubMed Beckmann MW, Niederacher D, Schnurch HG, Gusterson BA, Bender HG: Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med. 1997, 75: 429-439. 10.1007/s001090050128.CrossRefPubMed
19.
go back to reference Richard F, Pacyna-Gengelbach M, Schluns K, Fleige B, Winzer KJ, Szymas J, Dietel M, Petersen I, Schwendel A: Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer. 2000, 89: 305-310. 10.1002/1097-0215(20000520)89:3<305::AID-IJC15>3.3.CO;2-#.CrossRefPubMed Richard F, Pacyna-Gengelbach M, Schluns K, Fleige B, Winzer KJ, Szymas J, Dietel M, Petersen I, Schwendel A: Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer. 2000, 89: 305-310. 10.1002/1097-0215(20000520)89:3<305::AID-IJC15>3.3.CO;2-#.CrossRefPubMed
20.
go back to reference Climent J, Martinez-Climent JA, Blesa D, Garcia-Barchino MJ, Saez R, Sanchez-Izquierdo D, Azagra P, Lluch A, Garcia-Conde J: Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer. Clin Cancer Res. 2002, 8: 3863-3869.PubMed Climent J, Martinez-Climent JA, Blesa D, Garcia-Barchino MJ, Saez R, Sanchez-Izquierdo D, Azagra P, Lluch A, Garcia-Conde J: Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer. Clin Cancer Res. 2002, 8: 3863-3869.PubMed
21.
go back to reference Huiping C, Eiriksdottir G, Sigurdsson A, Sigurgeirsdottir JR, Barkardottir RB, Egilsson V, Ingvarsson S: High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content. Anticancer Res. 1998, 18: 1031-1036.PubMed Huiping C, Eiriksdottir G, Sigurdsson A, Sigurgeirsdottir JR, Barkardottir RB, Egilsson V, Ingvarsson S: High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content. Anticancer Res. 1998, 18: 1031-1036.PubMed
22.
go back to reference Hamaguchi M, Meth JL, Von Klitzing C, Wei W, Esposito D, Rodgers L, Walsh T, Welcsh P, King MC, Wigler MH: DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc Natl Acad Sci USA. 2002, 99 (21): 13647-52. 10.1073/pnas.212516099.CrossRefPubMedPubMedCentral Hamaguchi M, Meth JL, Von Klitzing C, Wei W, Esposito D, Rodgers L, Walsh T, Welcsh P, King MC, Wigler MH: DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc Natl Acad Sci USA. 2002, 99 (21): 13647-52. 10.1073/pnas.212516099.CrossRefPubMedPubMedCentral
23.
go back to reference Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, et al: DPC4 gene in various tumor types. Cancer Res. 1996, 56: 2527-2530.PubMed Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, et al: DPC4 gene in various tumor types. Cancer Res. 1996, 56: 2527-2530.PubMed
Metadata
Title
Allelic imbalances of chromosomes 8p and 18q and their roles in distant relapse of early stage, node-negative breast cancer
Authors
Aki Morikawa
Tanisha Y Williams
Luc Dirix
Cecile Colpaert
Michael Goodman
Robert H Lyles
Diansheng Zhong
Wei Zhou
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 6/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1349

Other articles of this Issue 6/2005

Breast Cancer Research 6/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine